| Financial Year |
March 31 2023 |
| Monetary Funds |
1,027,300,707.73 |
| Held-for-trading Financial Assets |
189,144,340.27 |
| Notes Receivable |
-- |
| Accounts Receivable |
101,571,114.89 |
| Advances to Suppliers |
18,260,777.26 |
| Other Receivables |
4,474,413.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
201,245,767.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,873,685.48 |
| Total Current Assets |
1,554,970,806.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
272,242,823.06 |
| Investment Properties |
-- |
| Fixed Assetes |
62,630,050.21 |
| Under-construction Projects |
6,273,801.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
84,353,873.50 |
| R&D expenses |
-- |
| Goodwill |
11,698,741.15 |
| Long-Term Deferred and Prepaid Expenses |
225,151.89 |
| Deferred Income Tax Assets |
4,405,774.99 |
| Other Non-Current Assets |
9,947,863.65 |
| Sub-Total of Non-Current Assets |
677,752,595.65 |
| Total Assets |
2,232,723,402.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
91,378,074.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,825,099.78 |
| Taxes Payable |
11,268,696.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,960,927.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,067,218.52 |
| Other Current Liabilities |
12,251,473.75 |
| Sub-Total of Current Liabilities |
230,993,595.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,874,868.92 |
| Total Liabilities |
235,868,464.87 |
| Paid-In Capital(Or Share Stock) |
225,204,580.00 |
| Capital Surplus |
804,927,834.72 |
| Surplus Reserve |
108,138,310.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
842,199,004.69 |
| Minority Stockholder's Interest |
26,462,205.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,970,392,731.42 |
| Owner's Equity（Stockholder's Equity） |
1,996,854,937.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,232,723,402.00 |
